Skip to main content

Table 3 The univariate analysis of prognosis related factors on 272 postterm choriocarcinoma patients

From: Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study

Clinical and demographics characteristics 5-year survival rate(%) P value
Age   
   <40 (n = 250) 88.0  
   ≥40 (n = 22) 72.7 0.13
Medical history of molar gestation   
   Yes (n = 48) 84.3  
   No (n = 224) 87.1 0.70
Interval from index pregnancy,month   
   ≤12 (n = 161) 93.2  
   >12 (n = 111) 79.0 0.01
Pretreatment β-hCG,mIU/ml   
   <100,000 (n = 220) 84.9  
   ≥ 100,000 (n = 52) 94.0 0.34
   <400,000 (n = 257) 86.3  
   ≥ 400,000 (n = 15) 93.3 0.79
Metastatic sites   
   1 (n = 195) 91.0  
   ≥2 (n = 77) 75.9 0.004
Abnormal uterine bleeding only   
   Yes (n = 139) 88.4  
   No (n = 133) 82.8 0.344
Fetal death or stillbirth   
   Yes (n = 14) 92.9  
   No (n = 258) 86.2 0.66
Resistance to multiagent chemotherapy   
   Yes (n = 121) 76.3  
   No (n = 151) 95.3 0.004
Brain metastasis   
   Yes (n = 41) 80.6  
   No (n = 231) 87.9 0.13
Kidney metastasis   
   Yes (n = 6) 83.3  
   No (n = 266) 86.7 0.55
Liver metastasis   
   Yes (n = 10) 33.3  
   No (n = 262) 89.0 0.000
Surgeries   
   Yes (n = 141) 85.5  
   No (n = 131) 87.4 0.25
FIGO score   
   ≤12 (n = 216) 90.9  
   >12 (n = 56) 71.3 0.000